Paul Streck - Net Worth and Insider Trading

Paul Streck Net Worth

The estimated net worth of Paul Streck is at least $232,870 dollars as of 2026-09-11. Paul Streck is the EVP, Head of R&D of PepGen Inc and owns about 76,226 shares of PepGen Inc (PEPG) stock worth over $232,870. Details can be seen in Paul Streck's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Streck has not made any transactions after 2026-03-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Paul Streck

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Paul Streck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Streck owns 4 companies in total, including Alder BioPharmaceuticals Inc (ALDR) , Insmed Inc (INSM) , and Albireo Pharma Inc (ALBO) among others .

Click here to see the complete history of Paul Streck’s form 4 insider trades.

Insider Ownership Summary of Paul Streck

Ticker Company Transaction Date Type of Owner
ALDR Alder BioPharmaceuticals Inc 2019-10-22 Chief Medical Officer
INSM Insmed Inc 2017-06-05 Chief Medical Officer
ALBO Albireo Pharma Inc 2022-12-19 Chief Medical Officer
LIMIT LIMIT 2026-03-04 EVP & Head of R&D

Paul Streck Latest Holdings Summary

Paul Streck currently owns a total of 1 stock. Paul Streck owns 76,226 shares of PepGen Inc (PEPG) as of March 4, 2026, with a value of $232,870.

Latest Holdings of Paul Streck

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PEPG PepGen Inc 2026-03-04 76,226 3.06 232,870

Holding Weightings of Paul Streck


Paul Streck Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Streck has made a total of 2 transactions in PepGen Inc (PEPG) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in PepGen Inc is the sale of 1,879 shares on March 4, 2026, which brought Paul Streck around $11,706.

Insider Trading History of Paul Streck

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Streck Trading Performance

GuruFocus tracks the stock performance after each of Paul Streck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Streck is -20.55%. GuruFocus also compares Paul Streck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Streck within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul Streck's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul Streck

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -23.97 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -28.93 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Paul Streck owns.
View PEPG Analysis

Paul Streck Ownership Network

Ownership Network List of Paul Streck

No Data

Ownership Network Relation of Paul Streck

Insider Network Chart


Paul Streck Owned Company Details

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

Paul Streck is the Chief Medical Officer of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Financial Officer Carlos Campoy , and director & President and CEO Robert Azelby .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

Paul Streck Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Streck. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul Streck's mailing address is: Boston Ma 02118.